The 5th Annual Viral Vector Process Development & Manufacturing Summit brings together leaders across CMC, process development, manufacturing, MSAT, operations, and regulatory affairs to advance robust, reliable, and reproducible viral vector manufacturing platforms. As the industry shifts towards optimizing proven AAV and LVV platforms, the summit focuses on overcoming the challenges of scalable manufacturing, process consistency, regulatory readiness, and commercial success.
The summit will showcase practical insights from leading biopharma and biotech organizations including Regeneron, Sanofi, Ultragenyx, Legend Biotech, Cabaletta Bio, and Apertura Gene Therapy, providing attendees with actionable strategies to strengthen manufacturing performance, improve product quality, and support successful clinical and commercial outcomes.
Join a community of viral vector experts dedicated to increasing productivity, reducing manufacturing and CMC burden, and building the scalable processes needed to deliver the next generation of cell and gene therapies.
Find out more today and secure your complimentary ticket: https://ter.li/2pthcqqz